Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

Cancer Biology & Therapy
Phillip C C LiuTimothy C Burn

Abstract

Overexpression and activating mutations of ErbB family members have been implicated in the development and progression of a variety of tumor types. Cleavage of the HER2 receptor by an as yet unidentified ectodomain sheddase has been shown to liberate the HER2 extracellular domain (ECD) leaving a fragment with constitutive kinase activity that can provide ligand-independent growth and survival signals to the cell. This process is clinically relevant since HER2 ECD serum levels in metastatic breast cancer patients are associated with a poorer prognosis. Thus, inhibition of the HER2 sheddase may provide a novel therapeutic approach for breast cancer. We describe the use of transcriptional profiling, pharmacological and in vitro approaches to identify the major source of HER2 sheddase activity. Real-time PCR was used to identify those ADAM family members which were expressed in HER2 shedding cell lines. siRNAs that selectively inhibited ADAM10 expression reduced HER2 shedding. In addition, we profiled over 1000 small molecules for in vitro inhibition of a panel of ADAM and MMP proteins; a positive correlation was observed only between ADAM10 inhibition and reduction of HER2 ECD shedding in a cell based assay. Finally, in vitro stud...Continue Reading

Citations

Feb 24, 2007·Journal of Mammary Gland Biology and Neoplasia·Pepper SchedinVirginia Borges
Jan 22, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaohong DengAnne-Sofie Schrohl
Apr 17, 2008·Nature Clinical Practice. Rheumatology·Marcia L MossRaphael Nudelman
Dec 12, 2012·Molecular & Cellular Proteomics : MCP·Bow J TauroRichard J Simpson
Jan 17, 2008·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Sei Kuriyama, Roberto Mayor
Apr 15, 2009·Molecular and Cellular Biology·Kim PedersenJoaquín Arribas
May 17, 2011·Retrovirology·Brian M FriedrichMonique R Ferguson
Oct 31, 2012·Journal of Cell Science·Lakmali AtapattuPeter W Janes
Sep 22, 2007·Drugs·Michael F Press, Heinz-Josef Lenz
Dec 22, 2009·Future Oncology·Maija Hollmén, Klaus Elenius
Jan 28, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Jean-Christophe TheryFrédérique Penault Llorca
Feb 18, 2014·Biochemical and Biophysical Research Communications·Yang KaiBian Zhuan
Feb 22, 2012·World Journal of Surgical Oncology·Hsiu-Pei TsaiLing-Ling Hsieh
Aug 8, 2014·Membranes·Vibeke Bertelsen, Espen Stang
Apr 29, 2015·Expert Review of Gastroenterology & Hepatology·Antonio FacciorussoMichele Barone
Jul 5, 2008·Expert Review of Molecular Diagnostics·Fernanda MilaneziFernando C Schmitt
Sep 23, 2008·Expert Opinion on Pharmacotherapy·Giulio MetroAlessandra Fabi
Nov 1, 2009·Expert Opinion on Medical Diagnostics·Fernanda MilaneziFernando Schmitt
Apr 24, 2012·Biochimica Et Biophysica Acta·Lian LamHongtao Zhang
Jun 28, 2011·Drug Discovery Today·Radoslaw ZagozdzonJohn Crown
May 2, 2009·Clinica Chimica Acta; International Journal of Clinical Chemistry·Michael J DuffyPatricia M McGowan
Nov 4, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yuvraj SinghManish K Chourasia
Oct 30, 2009·The Journal of Investigative Dermatology·Sophia B LeePaul Gutwein
Dec 4, 2008·Seminars in Cell & Developmental Biology·Karina Reiss, Paul Saftig
Oct 28, 2008·Seminars in Cell & Developmental Biology·Jessica Pruessmeyer, Andreas Ludwig
Aug 8, 2009·The Journal of Pathology·Harry van GoorStephen T Holgate
Dec 21, 2007·The Journal of Pathology·M J DuffyW M Gallagher
Feb 18, 2009·The FEBS Journal·Christian FreeseKristina Endres
Jan 4, 2012·Proteomics. Clinical Applications·Peter Findeisen, Michael Neumaier
Apr 20, 2011·Journal of Cellular Physiology·Carlos LizamaRicardo D Moreno
Jan 25, 2011·Journal of Surgical Oncology·Yuan-Yu WangHou-Quan Tao
Jan 3, 2013·International Journal of Cancer. Journal International Du Cancer·Neill PataniMitch Dowsett
Jun 13, 2015·SpringerPlus·Julia TchouHongtao Zhang
Jul 30, 2014·Seminars in Cancer Biology·Mohammad Hojjat-FarsangiHåkan Mellstedt
Nov 19, 2013·Biochemical and Biophysical Research Communications·Silvio WeberPaul Saftig

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.